<DOC>
	<DOCNO>NCT00586651</DOCNO>
	<brief_summary>This 18-week open-label , multicenter study evaluate efficacy tolerability CEP-701 ( lestaurtinib ) treatment patient Polycythemia Vera ( PV ) patient Essential Thrombocytosis ( ET ) .</brief_summary>
	<brief_title>Open-Label Study Oral CEP-701 ( Lestaurtinib ) Patients With Polycythemia Vera Essential Thrombocytosis</brief_title>
	<detailed_description>This 18-week open-label , multicenter study evaluate efficacy tolerability CEP-701 ( lestaurtinib ) treatment dosage 80 mg bid 18 week ( 126 day ) patient Polycythemia Vera ( PV ) abnormal baseline neutrophil count require hydroxyurea therapy patient Essential Thrombocytosis ( ET ) require hydroxyurea therapy disease control .</detailed_description>
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<criteria>The patient polycythemia vera ( PV ) essential thrombocytosis ( ET ) . The patient detectable JAK2 V617F mutation . Patients PV least 1 follow risk factor : 1. neutrophil count great 7000/mm3 2. receive hydroxyurea treatment Patients ET receive concomitant hydroxyurea . The patient ECOG performance score 0 , 1 , 2 . The patient bilirubin level aspartate transaminase ( AST ) level within exclusionary range . patient serum creatinine concentration within exclusionary range . patient untreated progressive infection . patient physical psychiatric condition may compromise participation study . history venous arterial thrombosis within 6 month . use hydroxyurea initiate escalated month prior screen . active gastrointestinal ulceration bleeding . patient use investigational drug within past 30 day . patient treat anagrelide . patient previously take CEP701 ( lestaurtinib ) . patient hypersensitivity CEP701 ( lestaurtinib ) component CEP701 ( lestaurtinib ) . patient receive interferon within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>